Compare Edwards Lifesciences Corporation Common Stock (EW) vs QUALCOMM, Inc. (QCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs QUALCOMM, Inc. — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.21 (market cap $48.56B), while QUALCOMM, Inc. trades at $175.5 (market cap $187.95B). The key difference: QUALCOMM, Inc. is far larger — about 3.9× Edwards Lifesciences Corporation Common Stock's market cap, and QUALCOMM, Inc. pays a 2.09% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | QCOM | |
|---|---|---|
Market Cap | $48.56B | $187.95B |
Volume | 6,520,488 | 9,535,042 |
Sector | Health | Technology |
52-Week High | $95.18 | $251.10 |
52-Week Low | $72.65 | $124.07 |
Enterprise Value | $45.01B | $194.92B |
Typical Hold Time | — | 87 Days |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Qualcomm (QCOM) trades at $176.01, down 0.59% on the day, with a bearish technical signal and key support at $173. The company reported mixed Q2 2026 earnings, missing EPS estimates, but maintains strong profitability with a 21.01% net margin and 33.75% ROE. Recent news highlights a transformative $60 billion AI partnership with Amazon, boosting sentiment despite near-term volatility.
QCOM presents a compelling risk-reward profile with a consensus price target of $204.48, implying 16% upside. Strengths include robust cash flow and diversification into AI/data centers, but risks involve execution on new initiatives and dependence on smartphone markets. Analyst consensus leans Hold, reflecting cautious optimism amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →
